Solana Company operates as a listed digital asset treasury. The company enhances Solana tokens per share on the commercially viable blockchain for decentralized finance and consumer applications. It also focuses on neurological wellness. In addition, the company offers Portable Neuromodulation Stimulator, a non-implantable medical device, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. Solana Company is headquartered in Newtown, Pennsylvania.…
Solana Company Q3 2026 Earnings Call Summary
Solana Company (NASDAQ: HSDT) is listed on Nasdaq, where its shares trade in USD. It belongs to the Asset Management industry, part of the Financial Services sector, and reports about 21 employees.
The shares were at 1.490 USD on 20 November 2026, down 72.9% over 52 weeks. Its 52-week range is 1.186 USD to 5.770 USD: the price is 74.2% below the high and 25.6% above the low.
Its market capitalisation is 93.70M USD.
Solana Company reports return on equity of -13.6% and revenue up 382.1% year over year.
It holds more cash than debt, a net cash position of 1.13M USD. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 2 analysts cover the stock, with an average rating of Buy; their mean price target of 3.000 USD is 101.3% above the current price.